Cathay Biotech Inc.
SSE:688065.SS
52.2 (CNY) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 742.828 | 770.79 | 749.935 | 675.85 | 539.741 | 535.06 | 524.984 | 505.446 | 603.382 | 548.858 | 627.597 | 661.266 | 564.694 | 618.483 | 527.237 | 487.044 | 344.935 | 358.812 | 387.882 | 405.562 | 329.797 | 477.358 | 509.248 | 599.795 |
| Cost of Revenue
| 531.809 | 508.521 | 520.104 | 488.181 | 400.216 | 395.636 | 390.608 | 333.447 | 394.125 | 349.917 | 414.255 | 422.545 | 363.868 | 391.495 | 312.858 | 271.643 | 115.091 | 192.273 | 229.88 | 211.144 | 168.2 | 256.013 | 261.003 | 335.824 |
| Gross Profit
| 211.019 | 262.269 | 229.831 | 187.67 | 139.525 | 139.424 | 134.376 | 171.999 | 209.257 | 198.942 | 213.343 | 238.722 | 200.826 | 226.988 | 214.379 | 215.4 | 229.844 | 166.539 | 158.003 | 194.418 | 161.597 | 221.345 | 248.245 | 263.971 |
| Gross Profit Ratio
| 0.284 | 0.34 | 0.306 | 0.278 | 0.259 | 0.261 | 0.256 | 0.34 | 0.347 | 0.362 | 0.34 | 0.361 | 0.356 | 0.367 | 0.407 | 0.442 | 0.666 | 0.464 | 0.407 | 0.479 | 0.49 | 0.464 | 0.487 | 0.44 |
| Reseach & Development Expenses
| 64.547 | 68.738 | 50.18 | 44.784 | 58.32 | 40.246 | 36.467 | 49.701 | 52.96 | 48.258 | 47.717 | 38.779 | 48.936 | 28.077 | 29.085 | 27.434 | 32.957 | 9.392 | 27.247 | 14.704 | 19.053 | 20.159 | 73.217 | 17.731 |
| General & Administrative Expenses
| -81.339 | 104.976 | -16.512 | 43.244 | -66.243 | 100.16 | -34.275 | 65.179 | -55.056 | 96.813 | -6.654 | 30.372 | -50.556 | 76.348 | -8.667 | 32.341 | -40.667 | 41.455 | 8.801 | 9.884 | -40.356 | 38.591 | 48.99 | 9.165 |
| Selling & Marketing Expenses
| -4.001 | 22.586 | 14.393 | 12.291 | 10.779 | 8.654 | 6.704 | 12.065 | 11.817 | 12.175 | 9.394 | 11.744 | 16.796 | 10.494 | -19.986 | 34.544 | 27.633 | 13.722 | 20.172 | 13.198 | 22.944 | 25.161 | 17.844 | 18.54 |
| SG&A
| -85.34 | 127.563 | 48.698 | 58.224 | 50.074 | 108.814 | -27.572 | 77.244 | -43.238 | 108.987 | 2.74 | 42.115 | -33.761 | 86.842 | -28.653 | 66.886 | -13.034 | 55.178 | 28.973 | 23.082 | -17.412 | 63.752 | 66.834 | 27.706 |
| Other Expenses
| 69.349 | -42.615 | -18.4 | -5.903 | -13.001 | -1.81 | -4.53 | -6.429 | 116.199 | -46.456 | 40.872 | -1.724 | -0.104 | 0.873 | 0.297 | 0.033 | 0.075 | 0.085 | -0.639 | -0.966 | -1.05 | -2.25 | 3.115 | -29.969 |
| Operating Expenses
| 48.556 | 153.685 | 117.278 | 108.911 | 121.395 | 66.766 | 41.387 | 120.516 | 125.92 | 110.789 | 91.329 | 79.17 | 94.245 | 75.292 | 44.192 | 92.966 | 80.803 | 52.895 | 63.669 | 56.328 | 75.383 | 75.296 | 112.763 | 68.455 |
| Operating Income
| 162.463 | 107.307 | 112.553 | 78.758 | 18.13 | 99.295 | 220.159 | 79.089 | 72.803 | 191.487 | 228.473 | 215.52 | 154.224 | 201.567 | 219.504 | 163.552 | 149.216 | 130.249 | 102.601 | 140.166 | 104.258 | 149.718 | 154.97 | 177.077 |
| Operating Income Ratio
| 0.219 | 0.139 | 0.15 | 0.117 | 0.034 | 0.186 | 0.419 | 0.156 | 0.121 | 0.349 | 0.364 | 0.326 | 0.273 | 0.326 | 0.416 | 0.336 | 0.433 | 0.363 | 0.265 | 0.346 | 0.316 | 0.314 | 0.304 | 0.295 |
| Total Other Income Expenses Net
| -1.82 | 0.397 | 46.672 | 0.331 | 0.856 | -1.81 | -2.049 | 0.113 | -0.907 | 3.882 | -14.735 | 0.37 | -0.73 | 2.063 | 0.867 | 0.033 | 0.075 | 0.085 | -0.543 | -0.966 | -1.05 | -2.25 | 3.115 | -29.969 |
| Income Before Tax
| 160.643 | 107.704 | 159.225 | 125.46 | 58.456 | 97.486 | 215.629 | 79.202 | 71.897 | 195.369 | 212.836 | 215.89 | 154.12 | 202.44 | 219.801 | 163.585 | 149.291 | 130.335 | 101.963 | 139.2 | 103.208 | 147.468 | 158.085 | 147.108 |
| Income Before Tax Ratio
| 0.216 | 0.14 | 0.212 | 0.186 | 0.108 | 0.182 | 0.411 | 0.157 | 0.119 | 0.356 | 0.339 | 0.326 | 0.273 | 0.327 | 0.417 | 0.336 | 0.433 | 0.363 | 0.263 | 0.343 | 0.313 | 0.309 | 0.31 | 0.245 |
| Income Tax Expense
| 24.488 | 12.177 | 19.823 | 16.937 | 1.416 | 8.61 | 23.014 | 7.349 | -9.955 | 32.907 | 35.845 | 24.54 | 20.529 | 28.511 | 22.042 | 22.179 | 13.245 | 15.468 | 13.823 | 20.911 | -3.09 | 28.077 | 27.429 | 24.572 |
| Net Income
| 143.785 | 97.732 | 142.187 | 105.259 | 52.639 | 72.027 | 184.416 | 57.441 | 67.085 | 149.729 | 161.903 | 174.549 | 117.905 | 163.579 | 185.113 | 141.294 | 136.377 | 114.867 | 88.139 | 118.289 | 106.298 | 119.39 | 130.656 | 122.536 |
| Net Income Ratio
| 0.194 | 0.127 | 0.19 | 0.156 | 0.098 | 0.135 | 0.351 | 0.114 | 0.111 | 0.273 | 0.258 | 0.264 | 0.209 | 0.264 | 0.351 | 0.29 | 0.395 | 0.32 | 0.227 | 0.292 | 0.322 | 0.25 | 0.257 | 0.204 |
| EPS
| 0.25 | 0.17 | 0.24 | 0.18 | 0.091 | 0.12 | 0.32 | 0.099 | 0.12 | 0.36 | 0.39 | 0.3 | 0.32 | 0.39 | 0.45 | 0.24 | 0.36 | 0.21 | 0.24 | 0.23 | 0.29 | 0.24 | 0.36 | 0.34 |
| EPS Diluted
| 0.25 | 0.17 | 0.24 | 0.18 | 0.091 | 0.12 | 0.32 | 0.099 | 0.12 | 0.36 | 0.39 | 0.3 | 0.32 | 0.39 | 0.45 | 0.24 | 0.36 | 0.21 | 0.24 | 0.23 | 0.29 | 0.24 | 0.36 | 0.34 |
| EBITDA
| 165.896 | 114.608 | 245.724 | 216.54 | 143.653 | 182.271 | 297.05 | 155.539 | 154.362 | 276.589 | 278.013 | 280.545 | 219.888 | 259.156 | 254.181 | 198.195 | 148.816 | 113.645 | 108.876 | 148.939 | 136.507 | 152.794 | 162.757 | 153.452 |
| EBITDA Ratio
| 0.223 | 0.149 | 0.328 | 0.32 | 0.266 | 0.341 | 0.566 | 0.308 | 0.256 | 0.504 | 0.443 | 0.424 | 0.389 | 0.419 | 0.482 | 0.407 | 0.431 | 0.317 | 0.281 | 0.367 | 0.414 | 0.32 | 0.32 | 0.256 |